Position in IMRX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$200,099
New position
Shares Held
40,100
first reported quarter
Ownership
0.062%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#54
of 111 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026WEALTH EFFECTS LLC holds $15,582,612 across 10 Biotechnology names. IMRX ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
147,300 | $12,006,423 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
121,850 | $1,066,796 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
11,000 | $604,340 | |
| 4 | HUMA |
Humacyte, Inc.
|
693,920 | $541,257 | |
| 5 | ALT |
Altimmune, Inc.
|
122,650 | $372,856 | |
| 6 | BEAM |
Beam Therapeutics Inc.
|
10,549 | $362,041 | |
| 7 | GLUE |
Monte Rosa Therapeutics, Inc.
|
10,099 | $244,395 | |
| 8 | IMRX |
Immuneering Corp
This page
|
40,100 | $200,099 |
All Filings in IMRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200,099 | 40,100 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||